Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
137M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3.31M
-
Shares change
-
+2.75M
-
Total reported value, excl. options
-
$17.8M
-
Value change
-
+$14.8M
-
Number of buys
-
32
-
Price
-
$5.37
Significant Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q4 2021
34 filings reported holding LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.31M shares
of 137M outstanding shares and own 2.41% of the company stock.
Largest 10 shareholders include LUMINUS MANAGEMENT LLC (1.26M shares), Nantahala Capital Management, LLC (435K shares), CANTOR FITZGERALD, L. P. (417K shares), VANGUARD GROUP INC (249K shares), PUTNAM INVESTMENTS LLC (242K shares), Covalis Capital LLP (135K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (133K shares), MILLENNIUM MANAGEMENT LLC (65.3K shares), BlackRock Inc. (56.9K shares), and STATE STREET CORP (45.6K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.